AI assistant
PEAKO LIMITED AGM Information 2024
65567_rns_2024-10-23_dffdf862-164a-451a-84a2-8b3a817084dc.pdf
AGM Information
Open in viewerOpens in your device viewer
PEAKO LIMITED
(ABN 79 131 843 868)
NOTICE OF ANNUAL GENERAL MEETING
NOTICE IS HEREBY GIVEN that the Annual General Meeting (Meeting) of the Members of Peako Limited (Company) will be held at Level 6, 350 Collins Street, Melbourne, Victoria, 3000, at 11.00am (AEDT) on Monday 25 November 2024.
ORDINARY BUSINESS
Annual Financial Report
To receive and consider the Financial Statements of the Company for the year ended 30 June 2024 and the reports of the Directors and Auditor thereon.
Resolution 1: Adoption of the Remuneration Report for the year ended 30 June 2024
To consider and if thought fit, to pass the following as a non-binding and advisory resolution in accordance with section 250R of the Corporations Act:
"To adopt the Remuneration Report as included in the Directors' Report for the year ended 30 June 2024."
Resolution 2: To consider the election of Gernot Abl as a Director of the Company
To consider and if thought fit, to pass the following as an ordinary resolution:
"That Gernot Abl, a Director appointed as an additional Director and holding office until the next general meeting of the Company after his appointment in accordance with the Company's Constitution and ASX Listing Rule 14.4, be elected as a Director of the Company."
Resolution 3: To consider the election of Louis Bucci as a Director of the Company
To consider and if thought fit, to pass the following as an ordinary resolution:
"That Louis Bucci, a Director appointed as an additional Director and holding office until the next general meeting of the Company after his appointment in accordance with the Company's Constitution and ASX Listing Rule 14.4, be elected as a Director of the Company."
Resolution 4: To consider the re-election of Dr Paul Kitto as a Director of the Company
To consider and if thought fit, to pass the following as an ordinary resolution:
"That Dr Paul Kitto, who retires as a Director pursuant to the Constitution and, being eligible, offers himself for re-election and is hereby elected as a Director of the Company."
SPECIAL BUSINESS
Resolution 5: 10% Placement Capacity under Listing Rule 7.1A
To consider and if thought fit, to pass the following resolution as a special resolution:
"That for the purposes of Listing Rule 7.1A and for all other purposes, the issue of up to 10% of the Company's share capital, calculated in accordance with Listing Rule 7.1A and on the terms and conditions set out in the Explanatory Memorandum, is approved."
OTHER BUSINESS
To transact any other business which may be properly brought before the Meeting in accordance with the Company's Constitution and the Corporations Act.
NOTES
Requisite Majorities
Resolutions 1 to 4 are ordinary resolutions and will be passed only if supported by a simple majority of the votes cast by Shareholders entitled to vote on the resolutions.
Resolution 5 is a special resolution and will passed only of supported by 75% of votes cast by members present and eligible to vote at the Meeting.
Voting Exclusion Statement
Resolution 1 - Remuneration Report
A vote may not be cast (in any capacity) on Resolution 1 by or on behalf of any of the following persons:
- (a) a member of the Key Management Personnel, details of whose remuneration are included in the Remuneration Report; or
- (b) a Closely Related Party of a member of the Key Management Personnel.
However, a person described in (a) or (b) may cast a vote on Resolution 1 if:
- (c) the person does so as a proxy appointed in writing that specifies how the proxy is to vote on the proposed resolution; and
- (d) the vote is not cast on behalf of a person described in (a) or (b).
Resolutions 2,3 and 4
There are no voting exclusions for Resolutions 2, 3 and 4.
Resolution 5 – 10% Placement Capacity
In accordance with the provisions of Chapter 2E of the Corporations Act 2001 and the requirements of ASX Listing Rule 7.1 the Company will disregard any votes cast in favour of this Resolution by or on behalf of a person who is expected to participate in, or will obtain a material benefit as a result of, the proposed grant (except a benefit solely by reason of being a Shareholder) or any associates of those persons. However, the Company will not disregard a vote if:
- (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or
- (a) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or
- (b) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:
- (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and
- (ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.
At the date of the Notice the Company had not approached any Member or an identifiable class of Members to participate in the issue of equity securities. No Member's vote will therefore be excluded under the voting exclusion statements in the Notice.
Explanatory Memorandum
The Explanatory Memorandum accompanying this Notice of Meeting is incorporated in and comprises part of this Notice of Meeting.
By order of the Board
PEAKO LIMITED
Justin Mouchacca Company Secretary 24 October 2024
EXPLANATORY NOTES TO THE BUSINESS OF THE MEETING
Note 1: Annual Financial Report of the Company
The Financial Statements and related reports for the last financial year are contained in the Company's 2024 Annual Report and will be laid before the Meeting. While no Resolution is required, Members are encouraged to ask questions of the Directors and the Auditor and make comments on the Financial Statements and reports.
The Auditor responsible for preparing the Auditor's Report for the year ended 30 June 2024, (or his representative) will attend the Meeting. The Chairman will also allow a reasonable opportunity for Members to ask the Auditor questions about the:
- a) conduct of the audit;
- b) preparation and content of the Auditor's Report;
- c) accounting policies adopted by the Company in relation to the preparation of the Consolidated Financial Statements; and
- d) independence of the Auditor in relation to the conduct of the audit.
To assist the Directors and the Auditor in responding to questions, please submit your questions by mail to Peako Limited, Level 1, 10 Yarra Street, South Yarra Vic 3141 or by email to [email protected] so they are received by no later than 5:00pm (AEDT) on Wednesday 13 November 2024, being five (5) business days prior to the Meeting.
As required under section 250PA of the Corporations Act, at the Meeting the Company will distribute a list setting out the questions directed to the Auditor that have been received in writing from Members, being questions the Auditor considers relevant to the content of the Auditor's Report or the conduct of the audit of the Consolidated Financial Statements for the year ended 30 June 2024. The Chairman will allow reasonable opportunity for the Auditor to respond to the questions set out in this list.
Note 2: Resolution 1 - Remuneration Report
The Remuneration Report, which is included in the Directors' Report section of the Company's 202 Annual Report, will be laid before the Meeting. While the Resolution to adopt it is not binding on the Company or the Directors, Members are encouraged to ask questions and make comments on the Remuneration Report. You should also note that the following voting restrictions apply in relation to voting on the Remuneration Report.
Voting exclusion statement
A vote may not be cast (in any capacity) on Resolution 1 by or on behalf of any of the following persons:
- a) a member of the Key Management Personnel, details of whose remuneration are included in the Remuneration Report; or
- b) a Closely Related Party of a member of the Key Management Personnel.
However, a person described in (a) or (b) may cast a vote on Resolution 1 if:
- c) the person does so as a proxy appointed in writing that specifies how the proxy is to vote on the proposed Resolution; and
- d) the vote is not cast on behalf of a person described in (a) or (b).
The Directors unanimously recommend eligible Members vote in favour of adopting the Remuneration Report.
Note 3: Resolution 2 - To consider the election of Gernot Abl as a Director of the Company
The Company's Constitution allows that the Directors may at any time appoint a person to be a Director, either to fill a casual vacancy or as an addition to the existing Directors, but so that the total number of Directors does not at any time exceed the maximum number specified by the Constitution. Any Director, other than a Managing Director, so appointed holds office only until the next following annual general meeting and is then eligible for re-election.
Mr Gernot Abl was appointed as a director of the Company on 20 August 2024 and is seeking reelection at the Meeting.
Biographical information for Mr Abl can be found in the Company's annual report and on the company's website: https://www.peako.com.au/. The Directors, other than Mr Abl, unanimously recommend all Members vote in favour of the election of Mr Abl.
Note 4: Resolution 3 - To consider the election of Louis Bucci as a Director of the Company
The Company's Constitution allows that the Directors may at any time appoint a person to be a Director, either to fill a casual vacancy or as an addition to the existing Directors, but so that the total number of Directors does not at any time exceed the maximum number specified by the Constitution. Any Director, other than a Managing Director, so appointed holds office only until the next following annual general meeting and is then eligible for re-election.
Dr Louis Bucci was appointed as a director of the Company on 20 August 2024 and is seeking reelection at the Meeting.
Biographical information for Dr Bucci can be found in the Company's annual report and on the company's website: https://www.peako.com.au/. The Directors, other than Dr Bucci, unanimously recommend all Members vote in favour of the election of Dr Bucci.
Note 5: Resolution 4 - To consider the re-election of Paul Kitto as a Director of the Company
The Company's Constitution requires that at every Annual General Meeting one third of the Directors (other than the Managing Director) shall, by rotation, retire from office and provides that such Director or Directors are eligible for re-election. Dr Kitto retires by rotation and is seeking re-election at the Meeting. Biographical information for Dr Kitto can be found in the Company's annual report and on the company's website: https://www.peako.com.au/. The Directors, other than Dr Kitto, unanimously recommend all Members vote in favour of the re-election of Dr Kitto.
Note 6: Resolution 5 - Approval of 10% Placement Capacity under Listing Rule 7.1A
Under Resolution 5, the Company is seeking members' approval of a Special Resolution to renew the Company's capacity to issue the maximum number of additional equity securities permitted under ASX Listing Rule 7.1A. This Listing Rule (LR) permits the placement of new equity securities (calculated in accordance with LR 7.1A.2) as described here:
ASX Listing Rule 7.1A.2 provides that eligible entities which have obtained shareholder approval at an annual general meeting may issue or agree to issue, during the 12 month period after the date of the annual general meeting, a number of Equity Securities calculated in accordance with the following formula:
(A x D) – E
- A = The number of fully paid ordinary shares on issue at the commencement of the 12 months immediately preceding the date of issue or agreement to issue:
- plus the number of fully paid ordinary securities issued in the 12 months under an exception to ASX Listing Rule 7.2 other than exception 9, 16 or 17;
- plus the number of fully paid ordinary securities issued in the relevant period on the conversion of convertible securities within ASX Listing Rule 7.2 exception 9 where:
- the convertible securities were issued or agreed to be issued before the commencement of the relevant period; or
- the issue of, or agreement to issue the convertible securities was approve or taken under these rules to have been approved under ASX Listing Rule 7.1 or 7.4;
- plus the number of fully paid ordinary securities issued in the relevant period under an agreement to issue securities within ASX Listing Rule 7.2 exception 16 where:
- the agreement was entered into before the commencement of the relevant period; or
- the agreement or issue was approved, or taken under these rules to have been approved under ASX Listing Rule 7.1 or rule 7.4;
- plus the number of any other fully paid ordinary securities issued in the relevant period with approval under 7.1 or rule 7.4;
- Plus the number of partly paid ordinary securities that became fully paid in the relevant period,
- less the number of fully paid ordinary securities cancelled in the last 12 months
Note that A has the same meaning in ASX Listing Rule 7.1 when calculating an entity's 15% placement capacity.
- D = 10%
- E = the number of equity securities issued or agreed to be issued under ASX Listing Rule 7.1A.2 in the last 12 months immediately preceding the date or issue of the shares where the issue or agreement has not been subsequently approved by the holders of its ordinary securities under ASX Listing Rule 7.4
As Resolution 5 is a Special Resolution, it requires approval of 75% of the votes cast by members present and eligible to vote at the Meeting.
Eligibility criteria
Under LR 7.1A an eligible entity may, subject to shareholder approval by way of special resolution, make such a 10% Placement in addition to the 15% new issue capacity available to ASX-listed entities under LR 7.1. An eligible entity for the purposes of LR 7.1A is an entity that is not included in the S&P/ASX 300 Index and has a market capitalisation of $300 million or less. The Company is not included in the S&P/ASX 300 Index and has a market capitalisation of significantly less than $300 million, so is an eligible entity.
Placement capacity under Listing Rule7.1A
As at the date of this Notice, the Company had 878,474,866 ordinary shares on issue. Therefore, in addition to any equity securities it can issue under LR 7.1, if Resolution 5 is approved, the Company will have capacity to issue up to 87,847,486 equity securities under LR 7.1A, being up to 10% of the 878,474,866 fully paid ordinary shares presently on issue, which is calculated using the formula above. However, the number of equity securities that may be issued under LR 7.1A may increase beyond 87,847,486, as the actual number of fully paid shares on issue may increase by the date of any issue that may be made should Resolution 5 be approved.
Minimum issue price
In accordance with LR 7.1A, equity securities issued under the 10% Placement can only be issued at a price that is equivalent to not less than 75% of the volume weighted average price (VWAP) of the Company's equity securities of the same class calculated over the 15 trading days on which trades in its Shares were recorded immediately before:
- the date on which the issue price of the equity securities is agreed; or
- the issue date (if the equity securities are not issued within ten trading days of the date on which the issue price is agreed).
10% Placement Period
Shareholder approval of the 10% Placement Facility under Listing Rule 7.1A commences on the date of the annual general meeting at which the approval is obtained and expires on the first to occur to the following:
- the date that is 12 months after the date of the annual general meeting at which the approval is obtained;
- the time and date of the Company's next annual general meeting; or
- the time and date of the approval by shareholders of ordinary securities of a transaction under ASX Listing Rules 11.1.2 (a significant change to the nature or scale of activities) or 11.2 (disposal of main undertaking.
Shareholder approval under LR 7.1A does not lapse if the Company's market capitalisation subsequently exceeds $300 million or it is included in the S&P/ASX 300 Index at some time during the placement period; provided the Company meets the criteria under LR 7.1A on the date of the Meeting.
Dilution to existing shareholdings
If Resolution 5 is approved by members and the Company issues equity securities under the 10% Placement, there is a potential risk of economic and voting dilution to existing shareholders as a result.
Further, as the market price of the equity securities may be significantly lower on the issue date of the 10% Placement than on the date of approval at the Meeting, and because equity securities may be issued at a price that is at a discount to the market price on the issue date, there is a risk that the 10% Placement may raise less funding than it would if it was based on current market prices.
The economic dilution will reflect that existing shareholders who do not participate in the 10% Placement will have their underlying economic interests in the Company's assets diluted pro rata to the dilution in their shareholdings.
Additionally, as the issue price of any equity securities issued under the 10% Placement capacity may be at a discount to the equivalent VWAP of the Company's Shares traded over the 15 trading days prior to their issue price being set or the equity securities being issued, a further economic effect of such a placement may be a reduction in the market price or value of their then existing equity holding in the capital of the Company. Whether such a reduction in market price or value occurs, and if so for how long it continues, will depend on factors not presently known, including the purpose for which the 10% Placement may be made. The converse outcomes may also occur.
It is not possible to set out further economic effects which may arise from the 10% Placement, as they are unknown in advance of such a placement being made.
Details of all issues of equity securities by Peako during the 12 months preceding the date of the meeting as required by Listing Rule 7.3A6.
There were no issuances in the preceding 12 months.
Table showing various hypothetical scenarios as required by Listing Rule 7.3A.4
As required by LR 7.3A.4, the table below shows a number of hypothetical scenarios for the 10% Placement where Variable "A" in the formula in LR 7.1A.2 (representing the Company's share capital) has increased by either 50% or 100% and the share price has decreased by 50% or increased by 100% from the approximate share price as at the date of this Notice.
| Issue Price | |||||||
|---|---|---|---|---|---|---|---|
| Variable 'A' inListing Rule 7.1A.2 | $0.00250% decreasein CurrentShare Price | $0.004Current SharePrice | $0.008100% increasein CurrentShare Price | ||||
| Current Variable A878,474,866 Shares | 10% VotingDilution | 87,847,487 Shares | |||||
| Fundsraised | $175,695 | $351,390 | $702,780 | ||||
| 50% increase incurrent Variable A1,317,712,299 Shares | 10% VotingDilution | 131,771,230 Shares | |||||
| Fundsraised | $263,542 | $527,085 | $1,054,170 | ||||
| 100% increase incurrent Variable A1,756,949,732 Shares | 10% VotingDilution | 175,694,973 Shares | |||||
| Fundsraised | $351,390 | $702,780 | $1,405,560 |
1 Rounded to nearest whole dollar
2 No of Shares rounded to nearest whole Share
The table has been prepared on the following hypothetical assumptions but the Company does not represent the assumptions will necessarily occur:
- the Company issues the maximum number of Shares available under the 10% Placement.
- any increase in Variable A (being the Company's issued share capital at the time of issue under the 10% Placement) is due solely to an issue of Shares which is an exception in LR 7.2; for example a pro-rata rights issue. However, a 15% placement under LR 7.1 does not increase Variable "A" for the purposes of calculating the placement capacity under LR 7.1A.
- the table shows only the effect of issues of shares under LR 7.1A, not under the 15% placement capacity available to ASX listed entities under LR 7.1.
- the table does not show the dilution that may be caused to any particular Shareholder by reason of placements of Shares under LR 7.1A, based on that Shareholder's holding at the date of the Meeting. For instance, Shareholders will have different outcomes depending on whether or not they participate in a pro-rata issue which has the effect of increasing Variable "A"; and
- the current price for shares is assumed to be $0.004, being the price on 7 October 2024 immediately prior to lodgement of this Notice with ASX.
Purpose of the 10% Placement
The Company may seek to issue equity securities under the 10% Placement at a cash issue price, in which case the Company would use the funds for existing projects, to fund new venture opportunities, as working capital generally or for other corporate purposes.
Allocation policy
The allottees of any equity securities to be issued under the 10% Placement capacity have not yet been determined. However, the allottees of equity securities could consist of current shareholders or new investors (or both), none of whom will be related parties of the Company.
No priority of application will be accorded to existing shareholders and, unless the 10% Placement was made with disclosure, the allottees will be excluded offerees under section 708(8), 708(10) or 708(11) of the Corporations Act.
Subject to the above provisos, the Company will determine the allottees and the manner of their selection at the time of the issue of the 10% Placement, having regard for the following factors:
- the purpose of the issue of equity securities;
- alternative methods for raising funds available to the Company at that time including, but not limited to, an entitlement issue or other offer where existing Shareholders may participate;
- the effect of the issue of equity securities on the control of the Company;
- the circumstances of the Company including, but not limited to, the financial position and solvency of the Company;
- prevailing market conditions; and
- advice from corporate, financial and broking advisors (if applicable).
Recommendation
The Directors believe Resolution 5 will provide the Company with the flexibility to raise capital quickly if advantageous terms are available or if required for funding the Company and where doing so is in the best interests of the Company.
The Directors unanimously recommend that all Members vote in favour of Resolution 5.
Peako Limited | ABN 79 131 843 868
Your proxy voting instruction must be received by 11.00am (AEDT) on Saturday, 23 November 2024, being not later than 48 hours before the commencement of the Meeting. Any Proxy Voting instructions received after that time will not be valid for the scheduled Meeting.
SUBMIT YOUR PROXY
Complete the form overleaf in accordance with the instructions set out below.
YOUR NAME AND ADDRESS
The name and address shown above is as it appears on the Company's share register. If this information is incorrect, and you have an Issuer Sponsored holding, you can update your address through the investor portal: https://investor.automic.com.au/#/home Shareholders sponsored by a broker should advise their broker of any changes.
STEP 1 – APPOINT A PROXY
If you wish to appoint someone other than the Chair of the Meeting as your proxy, please write the name of that Individual or body corporate. A proxy need not be a Shareholder of the Company. Otherwise if you leave this box blank, the Chair of the Meeting will be appointed as your proxy by default.
DEFAULT TO THE CHAIR OF THE MEETING
Any directed proxies that are not voted on a poll at the Meeting will default to the Chair of the Meeting, who is required to vote these proxies as directed. Any undirected proxies that default to the Chair of the Meeting will be voted according to the instructions set out in this Proxy Voting Form, including where the Resolutions are connected directly or indirectly with the remuneration of Key Management Personnel.
STEP 2 - VOTES ON ITEMS OF BUSINESS
You may direct your proxy how to vote by marking one of the boxes opposite each item of business. All your shares will be voted in accordance with such a direction unless you indicate only a portion of voting rights are to be voted on any item by inserting the percentage or number of shares you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on the items of business, your proxy may vote as he or she chooses. If you mark more than one box on an item your vote on that item will be invalid.
APPOINTMENT OF SECOND PROXY
You may appoint up to two proxies. If you appoint two proxies, you should complete two separate Proxy Voting Forms and specify the percentage or number each proxy may exercise. If you do not specify a percentage or number, each proxy may exercise half the votes. You must return both Proxy Voting Forms together. If you require an additional Proxy Voting Form, contact Automic Registry Services.
SIGNING INSTRUCTIONS
Individual: Where the holding is in one name, the Shareholder must sign.
Joint holding: Where the holding is in more than one name, all Shareholders should sign.
Power of attorney: If you have not already lodged the power of attorney with the registry, please attach a certified photocopy of the power of attorney to this Proxy Voting Form when you return it.
Companies: To be signed in accordance with your Constitution. Please sign in the appropriate box which indicates the office held by you.
Email Address: Please provide your email address in the space provided.
By providing your email address, you elect to receive all communications despatched by the Company electronically (where legally permissible) such as a Notice of Meeting, Proxy Voting Form and Annual Report via email.
CORPORATE REPRESENTATIVES
If a representative of the corporation is to attend the Meeting the appropriate 'Appointment of Corporate Representative' should be produced prior to admission. A form may be obtained from the Company's share registry online at https://automicgroup.com.au.
Lodging your Proxy Voting Form:
Online
Proxy Voting Form
If you are attending the Meeting in person, please bring this with you for Securityholder registration.
Use your computer or smartphone to appoint a proxy at
https://investor.automic.com.au/#/loginsah or scan the QR code below using your smartphone
Login & Click on 'Meetings'. Use the Holder Number as shown at the top of this Proxy Voting Form.
BY MAIL:
Automic GPO Box 5193 Sydney NSW 2001
IN PERSON:
Automic Level 5, 126 Phillip Street Sydney NSW 2000
BY EMAIL:
BY FACSIMILE: +61 2 8583 3040
All enquiries to Automic: WEBSITE:
PHONE:
1300 288 664 (Within Australia) +61 2 9698 5414 (Overseas)
STEP 1 - How to vote
APPOINT A PROXY:
I/We being a Shareholder entitled to attend and vote at the Annual General Meeting of Peako Limited, to be held at 11.00am (AEDT) on Monday, 25 November 2024 at Level 6, 350 Collins Street, Melbourne, Victoria, 3000 hereby:
Appoint the Chair of the Meeting (Chair) OR if you are not appointing the Chair of the Meeting as your proxy, please write in the box provided below the name of the person or body corporate you are appointing as your proxy or failing the person so named or, if no person is named, the Chair, or the Chair's nominee, to vote in accordance with the following directions, or, if no directions have been given, and subject to the relevant laws as the proxy sees fit and at any adjournment thereof.
| $\mathbf{r}$ | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $\overline{\phantom{a}}$_ | ||||||||||||||||||
The Chair intends to vote undirected proxies in favour of all Resolutions in which the Chair is entitled to vote.
Unless indicated otherwise by ticking the "for", "against" or "abstain" box you will be authorising the Chair to vote in accordance with the Chair's voting intention.
AUTHORITY FOR CHAIR TO VOTE UNDIRECTED PROXIES ON REMUNERATION RELATED RESOLUTIONS
Where I/we have appointed the Chair as my/our proxy (or where the Chair becomes my/our proxy by default), I/we expressly authorise the Chair to exercise my/our proxy on Resolution 1 (except where I/we have indicated a different voting intention below) even though Resolution 1 is connected directly or indirectly with the remuneration of a member of the Key Management Personnel, which includes the Chair.
| STEP 2 - Your voting direction | ||||
|---|---|---|---|---|
| Resolutions | For | Against | Abstain | |
| 1 | Adoption of the Remuneration Report for the year ended 30 June 2024 | |||
| 2 | To consider the election of Gernot Abl as a Director of the Company | |||
| 3 | To consider the election of Louis Bucci as a Director of the Company | |||
| 4 | To consider the re-election of Paul Kitto as a Director of the Company | |||
| 5 | 10% Placement Capacity under Listing Rule 7.1A | |||
Please note: If you mark the abstain box for a particular Resolution, you are directing your proxy not to vote on that Resolution on a show of hands or on a poll and your votes will not be counted in computing the required majority on a poll.
STEP 3 – Signatures and contact details
| Individual or Securityholder 1 | Securityholder 2 | Securityholder 3 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Sole Director and Sole Company Secretary | Director | Director / Company Secretary | |||||||
| Contact Name: | |||||||||
| Email Address: | |||||||||
| Contact Daytime TelephoneDate (DD/MM/YY) | |||||||||
| // | |||||||||
| By providing your email address, you elect to receive all communications despatched by the Company electronically (where legally permissible). |